BIOREM Inc.
BRM.V
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -50.47% | -39.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -50.47% | -39.03% | |||
| Cost of Revenue | -54.24% | -23.77% | |||
| Gross Profit | -32.24% | -69.00% | |||
| SG&A Expenses | -22.98% | -36.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -851.61% | |||
| Total Operating Expenses | -49.41% | -26.21% | |||
| Operating Income | -78.82% | -89.18% | |||
| Income Before Tax | -79.44% | -92.17% | |||
| Income Tax Expenses | -81.10% | -91.51% | |||
| Earnings from Continuing Operations | -78.77% | -92.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -78.77% | -92.41% | |||
| EBIT | -78.82% | -89.18% | |||
| EBITDA | -50.21% | -87.68% | |||
| EPS Basic | -82.05% | -92.33% | |||
| Normalized Basic EPS | -82.35% | -92.14% | |||
| EPS Diluted | 108.38% | -119.31% | |||
| Normalized Diluted EPS | -82.35% | -90.72% | |||
| Average Basic Shares Outstanding | 18.67% | -0.89% | |||
| Average Diluted Shares Outstanding | 18.67% | -16.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||